{
  "object_id": "revive:valsartan-160mg",
  "object_type": "Dose Decision Object",
  "schema_version": "1.0",
  "language": "en",
  "canonical_url": "/valsartan-160mg/",
  "canonical_page_h1": "Valsartan 160mg: Dose Decision Guide",
  "entity_slug": "valsartan-160mg",
  "primary_entity": "valsartan",
  "entity_family": "ARBs",
  "page_kind": "dose",
  "decision_stage": "BOFU / decision",
  "ymyl": true,
  "source_phase": "Phase 2 Answer-First Citation Blocks",
  "decision_dimensions": [
    "dose_role",
    "effectiveness",
    "response",
    "tolerability",
    "escalation",
    "deescalation",
    "monitoring",
    "interactions",
    "comorbidity",
    "adherence",
    "switching",
    "comparison",
    "safety",
    "patient_context",
    "natural_language",
    "summary"
  ],
  "answers": [
    {
      "query_id": "RZQ-02425",
      "question": "What does valsartan 160 mg mean in the drug's overall dosing range?",
      "short_answer": "Compare Valsartan 160mg: Dose Decision Guide by approved use, dosing context, risk profile, interactions, follow-up monitoring, purchase expense factors and practical treatment decisions. Valsartan 160 mg should be interpreted according to the condition it is being used to treat. A dose discussion for hypertension is not automatically the same as a dose discussion in another cardiovascular setting.",
      "citations": [
        {
          "label": "MedlinePlus drug information: Valsartan",
          "url": "https://medlineplus.gov/druginfo/meds/a697015.html"
        },
        {
          "label": "DailyMed current human drug-label search: Valsartan",
          "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=valsartan"
        },
        {
          "label": "Clinical guideline context: ACC/AHA 2025 High Blood Pressure Guideline",
          "url": "https://www.acc.org/Guidelines/Guidelines/2025/08/14/10/42/High-Blood-Pressure-in-Adults-2025"
        }
      ]
    },
    {
      "query_id": "RZQ-02426",
      "question": "Why might valsartan 160 mg be chosen instead of a lower or higher strength?",
      "short_answer": "Compare Valsartan 160mg: Dose Decision Guide by approved use, dosing context, risk profile, interactions, follow-up monitoring, purchase expense factors and practical treatment decisions. Valsartan 160 mg should be interpreted according to the condition it is being used to treat. A dose discussion for hypertension is not automatically the same as a dose discussion in another cardiovascular setting.",
      "citations": [
        {
          "label": "MedlinePlus drug information: Valsartan",
          "url": "https://medlineplus.gov/druginfo/meds/a697015.html"
        },
        {
          "label": "DailyMed current human drug-label search: Valsartan",
          "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=valsartan"
        },
        {
          "label": "Clinical guideline context: ACC/AHA 2025 High Blood Pressure Guideline",
          "url": "https://www.acc.org/Guidelines/Guidelines/2025/08/14/10/42/High-Blood-Pressure-in-Adults-2025"
        }
      ]
    },
    {
      "query_id": "RZQ-02427",
      "question": "Is valsartan 160 mg usually a starting, middle, or upper-range dose decision?",
      "short_answer": "Compare Valsartan 160mg: Dose Decision Guide by approved use, dosing context, risk profile, interactions, follow-up monitoring, purchase expense factors and practical treatment decisions. Valsartan 160 mg should be interpreted according to the condition it is being used to treat. A dose discussion for hypertension is not automatically the same as a dose discussion in another cardiovascular setting.",
      "citations": [
        {
          "label": "MedlinePlus drug information: Valsartan",
          "url": "https://medlineplus.gov/druginfo/meds/a697015.html"
        },
        {
          "label": "DailyMed current human drug-label search: Valsartan",
          "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=valsartan"
        },
        {
          "label": "Clinical guideline context: ACC/AHA 2025 High Blood Pressure Guideline",
          "url": "https://www.acc.org/Guidelines/Guidelines/2025/08/14/10/42/High-Blood-Pressure-in-Adults-2025"
        }
      ]
    }
  ],
  "related_questions": [
    {
      "query_id": "RZQ-02425",
      "question": "What does valsartan 160 mg mean in the drug's overall dosing range?",
      "priority": "P1",
      "micro_intent": "dose_role"
    },
    {
      "query_id": "RZQ-02426",
      "question": "Why might valsartan 160 mg be chosen instead of a lower or higher strength?",
      "priority": "P1",
      "micro_intent": "dose_role"
    },
    {
      "query_id": "RZQ-02427",
      "question": "Is valsartan 160 mg usually a starting, middle, or upper-range dose decision?",
      "priority": "P1",
      "micro_intent": "dose_role"
    },
    {
      "query_id": "RZQ-02428",
      "question": "What should someone expect to evaluate after using valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "effectiveness"
    },
    {
      "query_id": "RZQ-02429",
      "question": "If valsartan 160 mg is not working well enough, does that automatically mean the dose should be increased?",
      "priority": "P2",
      "micro_intent": "response"
    },
    {
      "query_id": "RZQ-02430",
      "question": "How can someone tell whether valsartan 160 mg is doing what it is supposed to do?",
      "priority": "P2",
      "micro_intent": "response"
    },
    {
      "query_id": "RZQ-02431",
      "question": "What side effects would make valsartan 160 mg worth reviewing?",
      "priority": "P2",
      "micro_intent": "tolerability"
    },
    {
      "query_id": "RZQ-02432",
      "question": "When can a lower dose than valsartan 160 mg become a reasonable discussion?",
      "priority": "P2",
      "micro_intent": "tolerability"
    },
    {
      "query_id": "RZQ-02433",
      "question": "What evidence would justify moving above valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "escalation"
    },
    {
      "query_id": "RZQ-02434",
      "question": "What evidence would justify stepping down from valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "deescalation"
    },
    {
      "query_id": "RZQ-02435",
      "question": "What monitoring matters after starting or changing to valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "monitoring"
    },
    {
      "query_id": "RZQ-02436",
      "question": "Can other medicines change how valsartan 160 mg should be evaluated?",
      "priority": "P2",
      "micro_intent": "interactions"
    },
    {
      "query_id": "RZQ-02437",
      "question": "How can kidney, liver, heart, or vascular conditions affect the decision around valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "comorbidity"
    },
    {
      "query_id": "RZQ-02438",
      "question": "Could timing or missed doses make valsartan 160 mg look ineffective?",
      "priority": "P2",
      "micro_intent": "adherence"
    },
    {
      "query_id": "RZQ-02439",
      "question": "When should someone consider changing the drug instead of changing valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "switching"
    },
    {
      "query_id": "RZQ-02440",
      "question": "How is valsartan 160 mg different from the nearest lower strength?",
      "priority": "P2",
      "micro_intent": "comparison"
    },
    {
      "query_id": "RZQ-02441",
      "question": "How is valsartan 160 mg different from the nearest higher strength?",
      "priority": "P2",
      "micro_intent": "comparison"
    },
    {
      "query_id": "RZQ-02442",
      "question": "What are the main safety questions to ask before changing valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "safety"
    },
    {
      "query_id": "RZQ-02443",
      "question": "What if valsartan 160 mg works but causes side effects?",
      "priority": "P2",
      "micro_intent": "patient_context"
    },
    {
      "query_id": "RZQ-02444",
      "question": "What if valsartan 160 mg is tolerated but the treatment goal is not reached?",
      "priority": "P2",
      "micro_intent": "patient_context"
    },
    {
      "query_id": "RZQ-02445",
      "question": "I am taking valsartan 160 mg. What should I track before asking for a dose change?",
      "priority": "P2",
      "micro_intent": "natural_language"
    },
    {
      "query_id": "RZQ-02446",
      "question": "My doctor mentioned valsartan 160 mg. What questions should I ask before changing doses?",
      "priority": "P2",
      "micro_intent": "natural_language"
    },
    {
      "query_id": "RZQ-02447",
      "question": "How do I know whether the problem is the dose or the medication itself with valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "natural_language"
    },
    {
      "query_id": "RZQ-02448",
      "question": "What is the most important decision logic around valsartan 160 mg?",
      "priority": "P2",
      "micro_intent": "summary"
    }
  ],
  "evidence": [
    {
      "label": "MedlinePlus drug information: Valsartan",
      "url": "https://medlineplus.gov/druginfo/meds/a697015.html"
    },
    {
      "label": "DailyMed current human drug-label search: Valsartan",
      "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=human&query=valsartan"
    },
    {
      "label": "Clinical guideline context: ACC/AHA 2025 High Blood Pressure Guideline",
      "url": "https://www.acc.org/Guidelines/Guidelines/2025/08/14/10/42/High-Blood-Pressure-in-Adults-2025"
    }
  ],
  "review": {
    "visible_page_review_date": null,
    "object_generated_date": "2026-09-11",
    "claim_level_confidence": "not_assigned",
    "confidence_note": "This object preserves answer text and citations already present on the canonical page. Claim-level confidence scoring and source-provenance grading are deferred to the later evidence/provenance phase."
  },
  "safety": {
    "educational_only": true,
    "not_individual_prescribing_advice": true,
    "do_not_stop_or_change_prescription_without_clinician_review": true
  },
  "implementation": {
    "preferred_rendering": "answer-first blocks + machine-readable JSON",
    "new_url_required": false,
    "canonical_page_remains_primary": true
  }
}